###begin article-title 0
Liver fibrosis secondary to bile duct injury: correlation of Smad7 with TGF-beta and extracellular matrix proteins
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 570 585 564 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGF-&#946;, Col I</italic>
###xml 587 594 578 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col III</italic>
###xml 596 602 587 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col IV</italic>
###xml 607 613 598 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PAI-1 </italic>
Liver fibrosis is the result of continuous liver injury stemming from different etiological factors. Bile duct injury induces an altered expression of TGF-beta, which has an important role in liver fibrosis because this cytokine induces the expression of target genes such as collagens, PAI-1, TIMPs, and others that lead to extracellular matrix deposition. Smad7 is the principal inhibitor that regulates the target gene transcription of the TGF-beta signaling. The aim of the study was to determine whether Smad7 mRNA expression correlates with the gene expression of TGF-beta, Col I, Col III, Col IV, or PAI-1 in liver fibrosis secondary to bile duct injury (BDI).
###end p 2
###begin title 3
Results
###end title 3
###begin p 4
###xml 289 291 286 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 47 55 <span type="species:ncbi:9606">patients</span>
###xml 205 213 <span type="species:ncbi:9606">patients</span>
###xml 302 310 <span type="species:ncbi:9606">patients</span>
Serum TGF-beta concentration was higher in BDI patients (39 296 pg/ml) than in liver donors (9008 pg/ml). Morphometric analysis of liver sections showed 41.85% of tissue contained fibrotic deposits in BDI patients. mRNA expression of Smad7, Col I, and PAI-1 was also significantly higher (P < 0.05) in patients with BDI than in controls. Smad7 mRNA expression correlated significantly with TGF-beta concentration, Col I and Col III expression, and the amount of fibrosis.
###end p 4
###begin title 5
Conclusion
###end title 5
###begin p 6
###xml 187 193 184 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smad7 </italic>
###xml 238 257 235 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGF-&#946;, collagens</italic>
###xml 263 268 257 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PAI-1</italic>
###xml 124 132 <span type="species:ncbi:9606">patients</span>
###xml 339 347 <span type="species:ncbi:9606">patients</span>
We found augmented serum concentration of TGF-beta and an increase in the percentage of fibrotic tissue in the liver of BDI patients. Contrary to expected results, the 6-fold increase in Smad7 expression did not inhibit the expression of TGF-beta, collagens, and PAI-1. We also observed greater expression of Col I and Col III mRNA in BDI patients and significant correlations between their expression and TGF-beta concentration and Smad7 mRNA expression.
###end p 6
###begin title 7
Background
###end title 7
###begin p 8
###xml 319 320 319 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 321 322 321 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 569 570 569 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 571 572 571 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
Liver fibrosis is caused mainly by alcohol consumption and viral hepatitis, and it is an important health problem throughout the world. Bile duct injury (BDI) is also an important etiological factor because it can cause secondary biliary cirrhosis and long-term disability, and it increases the risk of death threefold[1,2]. BDI can occur as a complication of cholecystectomy, an elective surgery for cholelithiasis. The introduction of laparoscopy has increased the BDI incidence to 0.3-1.0%, which is higher than that associated with open cholecystectomy (0.1-0.3%) [3-5].
###end p 8
###begin p 9
###xml 493 494 493 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 495 496 495 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 497 498 497 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
BDI causes obstruction of bile ducts, which results in cholestasis. BDI increases the concentrations of serum aminotransferases, bilirubin, and alkaline phosphatase (AP). As the obstruction proceeds, the accumulation of biliary salts in the canalicular membrane produces dilatation of bile ducts, which may rupture and form bile deposits. Mononuclear cells infiltrate into the portal tracts and bile ducts proliferate, leading to degeneration of hepatocytes and periportal fibrosis deposition[3,6-8].
###end p 9
###begin p 10
###xml 427 428 418 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 429 431 420 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
Transforming growth factor-beta (TGF-beta) is a multifunctional cytokine involved in the regulation of cell proliferation, differentiation, extracellular matrix (ECM) production, wound healing, and tissue repair. TGF-beta plays an important role in liver fibrogenesis because it triggers the overexpression and deposition in the ECM of molecules such as PAI-1, TIMP-1, Col I, Col III, Col IV, tenascin, fibronectin, and Smad7 [9-14].
###end p 10
###begin p 11
###xml 104 106 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 107 109 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
Smad7 is the principal inhibitor that regulates the target gene transcription of the TGF-beta signaling[15,16]. Smad7 exerts its inhibitory effect by its association with activated TGF-beta I receptor and inhibition of Smad2/3 phosphorylation.
###end p 11
###begin p 12
###xml 93 95 90 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 96 98 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 114 116 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 136 138 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 301 303 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 304 306 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 307 309 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 409 411 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 663 671 660 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGF-&#946;</italic>
###xml 673 678 667 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col I</italic>
###xml 680 687 674 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col III</italic>
###xml 689 695 683 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col IV</italic>
###xml 697 707 691 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">and PAI-1 </italic>
###xml 522 527 <span type="species:ncbi:9606">human</span>
###xml 720 728 <span type="species:ncbi:9606">patients</span>
Smad7 has been used in experimental models to block TGF-beta effects in different disorders [17-19]. Dooley et al[20] and Tahashi et al[16] demonstrated that Smad7 expression was low in experimental liver fibrosis, and this event allows liver scar formation. Some investigators have used gene therapy[16,20,21] with an adenoviral vector containing Smad7 complementary DNA (cDNA) and a Chinese herbal medicine[22], to treat fibrosis and cirrhosis in different experimental models. However, there are no reports on Smad7 in human liver fibrosis. In this context, the aim of our study was to determine whether Smad7 mRNA expression correlates with the expression of TGF-beta, Col I, Col III, Col IV, and PAI-1 genes in BDI patients and to compare these relationships with controls (liver donors).
###end p 12
###begin title 13
Methods
###end title 13
###begin title 14
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and samples
###end title 14
###begin p 15
###xml 981 984 981 984 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nd </sup>
###xml 9 17 <span type="species:ncbi:9606">patients</span>
###xml 56 64 <span type="species:ncbi:9606">patients</span>
###xml 179 187 <span type="species:ncbi:9606">patients</span>
###xml 636 643 <span type="species:ncbi:9606">patient</span>
###xml 747 755 <span type="species:ncbi:9606">patients</span>
###xml 1152 1159 <span type="species:ncbi:9606">patient</span>
Eighteen patients were included in this study. Fourteen patients had extrahepatic BDI caused by open or laparoscopic cholecystectomy that had been reconstructed surgically. These patients were recruited from Centro Medico General de Occidente, and 4 liver donors with normal liver histology, recruited from the Hospital Civil de Guadalajara, were included as a control group. The serum concentrations of alanine aminotransferase (ALT), aspartate aminotransferase (AST), direct bilirubin (DB), and AP were measured before the reconstruction surgery. Serum was obtained from a peripheral blood (PB) sample without anticoagulant from each patient and control. Liver biopsy specimens were obtained during bile duct reconstruction surgery. None of the patients or controls had a clinical history of previous liver disease or alcohol or drug abuse. The study protocol was in accordance to the ethical guidelines of the World Medical Association Declaration of Helsinki (adopted by the 52nd WMA General Assembly, Edinburgh, Scotland, October 2000) and was approved by the ethical committee of the institutions. Informed written consent was obtained from each patient and control.
###end p 15
###begin title 16
Histological analysis
###end title 16
###begin p 17
The liver specimens were fixed immediately in 4% paraformaldehyde solution, buffered to pH 7.4, and embedded in paraffin. Five-micrometer sections were cut and stained with Masson's trichrome. The proportion of each field displaying fibrosis was analyzed using computer image analysis software (Image Pro Plus 4.0). Briefly, regions of the section with the optical density characteristics of fibrosis where counted and analyzed as a percentage of the total tissue. The total collagen surface density was measured in 20 random fields at a magnification of 20x and is expressed as the percentage of total section area.
###end p 17
###begin title 18
ELISA for TGF-beta
###end title 18
###begin p 19
An ELISA kit (R&D Systems) was used to measure the serum concentration of TGF-beta following the manufacturer's protocol. The samples were activated by adding 200 mul in a tube with 200 mul of 2.5 M acetic acid, mixed, incubated for 10 min at room temperature, and inactivated with 200 mul of 2.7 M NaOH in 1 M HEPES. One hundred microliters of the activated sample, negative control, and the standards were added to the plate in triplicate. The absorbance was measured at 450 nm.
###end p 19
###begin title 20
RNA extraction
###end title 20
###begin p 21
Total RNA was extracted from a section of each liver biopsy using Trizol (Invitrogentrade mark) according to the manufacturer's instructions. The tissue was homogenized with 500 mul of Trizol. Chloroform (Sigma) was added and the sample was centrifuged at 10,000 rpm at 4degreesC. The total RNA was precipitated with isopropanol (Sigma). The RNA pellet was washed with 75% ethanol and dissolved in diethylene pyrocarbonate (DEPC) water. The final concentration and quality of RNA were determined by spectrophotometry, and the absorbance was measured at 260 and 280 nm.
###end p 21
###begin title 22
Reverse transcription and real-time Polymerase chain reaction (PCR)
###end title 22
###begin p 23
Total RNA was reverse transcribed to cDNA using SuperScript III (Invitrogentrade mark) enzyme. Two hundred nanograms of total RNA, 1 mul of 10 mM dNTP mix, 1 mul of (0.125 mug/mul) random primers, and DEPC water up to 13 mul were incubated at 70degreesC for 5 min. Four microliters of 5x first-strand buffer, 1 mul of 0.1 M DTT, 1 mul of RNaseOUT, and 1 mul of SuperScript III were added, and the samples were incubated at 25degreesC for 5 min (annealing), at 50degreesC for 50 min (cDNA synthesis), and at 72degreesC for 15 min (enzyme denaturation).
###end p 23
###begin p 24
###xml 375 383 375 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGF-&#946;</italic>
###xml 385 390 382 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col I</italic>
###xml 392 399 389 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col III</italic>
###xml 401 407 398 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col IV</italic>
###xml 409 414 406 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PAI-1</italic>
###xml 420 426 417 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smad7 </italic>
###xml 433 434 430 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
Real-time PCR was performed with an ABI Prism 7500 Sequence Detection System (Applied Biosystems). Two microliters of cDNA was used in each PCR reaction. The housekeeping gene 18S rRNA (Applied Biosystems) was used for normalization and water was used as a no-template control. The primers and probes (Applied Biosystems) for the PCR reaction were those for the target genes TGF-beta, Col I, Col III, Col IV, PAI-1, and Smad7 (Table 1).
###end p 24
###begin p 25
Primers and probes of the genes studied
###end p 25
###begin p 26
Each sample was analyzed in triplicate. Two microliters of each cDNA sample was mixed with 7 mul of DEPC water, 10 mul of Universal Master Mix (Applied Biosystems), and 1 mul of primer and probe (Applied Biosystems) of either the housekeeping or the target gene. Twenty microliters of this mixture was added to each well for each sample.
###end p 26
###begin p 27
###xml 64 66 56 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T </sub>
###xml 84 86 76 78 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T </sub>
###xml 140 142 128 130 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T </sub>
###xml 164 166 152 154 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T </sub>
###xml 211 213 195 197 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T </sub>
###xml 268 270 248 250 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T </sub>
###xml 310 311 282 283 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
###xml 469 483 441 447 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-&#916;&#916;CT </sup>
The relative quantification was calculated using the DeltaDeltaCT method. The mean CT of triplicate samples was used to calculate the DeltaCT as the difference in CT between the target and reference gene. DeltaCT for each sample minus the experimental reference DeltaCT control was expressed as the DeltaDeltaCT. The relative quantification is expressed as the fold expression of the target gene compared with the reference control expression according to the formula 2-DeltaDeltaCT and expressed in relative expression units (REU).
###end p 27
###begin title 28
Statistics
###end title 28
###begin p 29
###xml 52 54 50 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t </italic>
###xml 126 127 124 125 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s</sub>
###xml 194 196 192 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
The results are expressed as mean +/- SD. Student's t test was used to analyze differences between groups, and the Spearman (rs) correlation was used to analyze relationships between variables. P values < 0.05 were considered significant.
###end p 29
###begin title 30
Results
###end title 30
###begin title 31
Biochemical studies
###end title 31
###begin p 32
###xml 264 265 264 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 11 19 <span type="species:ncbi:9606">patients</span>
###xml 24 29 <span type="species:ncbi:9606">women</span>
###xml 36 39 <span type="species:ncbi:9606">men</span>
###xml 185 193 <span type="species:ncbi:9606">patients</span>
The 14 BDI patients (10 women and 4 men) had a mean age of 43.9 years (range, 17-65 years), and the 4 controls (liver donors) had a mean age of 37.2 years (range, 21-61 years). The BDI patients had higher concentrations of the aminotransferases, DB, and AP (Table 2).
###end p 32
###begin p 33
###xml 72 80 <span type="species:ncbi:9606">patients</span>
Clinical and biochemical features of control and bile duct injury (BDI) patients groups
###end p 33
###begin p 34
###xml 0 7 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224; </sup>
dagger = without lesion
###end p 34
###begin p 35
NA = not available
###end p 35
###begin title 36
Bismuth classification
###end title 36
###begin p 37
###xml 66 68 66 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 173 174 173 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 74 82 <span type="species:ncbi:9606">patients</span>
###xml 334 341 <span type="species:ncbi:9606">patient</span>
According to the Bismuth classification method for iatrogenic BDI[23], 11 patients were classified with lesion type 3, 2 with lesion type 2, and 1 with lesion type 1 (Table 2). The lesion type did not correlate with the mRNA expression, with the extent of fibrosis, or serum TGF-beta concentration. Further experiments, with a larger patient group, will be necessary to prove if the type or severity of BDI does or does not influence the liver fibrosis process.
###end p 37
###begin title 38
Liver fibrosis
###end title 38
###begin p 39
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1B</xref>
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1A</xref>
###xml 389 391 389 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 408 409 408 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 95 103 <span type="species:ncbi:9606">patients</span>
###xml 496 503 <span type="species:ncbi:9606">patient</span>
###xml 561 569 <span type="species:ncbi:9606">patients</span>
###xml 627 635 <span type="species:ncbi:9606">patients</span>
Liver biopsies stained with Masson's trichrome stain showed significant collagen levels in BDI patients (Figure 1B) we correlated collagen levels with increases in fibrosis. Less of the ECM was stained in the livers of the controls (Figure 1A). The morphometric analysis was correlated with an average of 41.85% fibrosis in the BDI group compared with 0.83% fibrosis in the control group (P = 0.001) (Figure 2). The increase in collagen staining did not correlate with the lesion type in the BDI patient group, probably because of the variety of types in these patients. In the morphological examination of liver biopsies from patients, we observed cholestasis, fibrosis around portal triad, proliferation of bile ducts and periportal inflammatory infiltrate.
###end p 39
###begin p 40
###xml 0 14 0 14 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Liver fibrosis</bold>
###xml 106 113 <span type="species:ncbi:9606">patient</span>
Liver fibrosis. The liver section stained with Masson's trichrome from a control (A), compared with a BDI patient (B) showed significant deposition of ECM proteins (blue stain) in B.
###end p 40
###begin p 41
###xml 0 44 0 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Percent optical density of collagen staining</bold>
###xml 123 131 <span type="species:ncbi:9606">patients</span>
Percent optical density of collagen staining. Morphometric analysis demonstrates more fibrosis in a liver section from BDI patients, who had an average of 41.85% fibrosis in liver tissue, which differed significantly from the percentage in the control group.
###end p 41
###begin title 42
Serum TGF-beta concentration
###end title 42
###begin p 43
###xml 249 250 243 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3</xref>
###xml 391 393 385 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 70 78 <span type="species:ncbi:9606">patients</span>
###xml 140 148 <span type="species:ncbi:9606">patients</span>
###xml 211 219 <span type="species:ncbi:9606">patients</span>
###xml 327 335 <span type="species:ncbi:9606">patients</span>
TGF-beta concentration was measured in the PB of only 9 of the 14 BDI patients because it was not possible to obtain blood samples from all patients. Serum TGF-beta concentration was significantly higher in the patients than in the controls (Figure 3). The mean concentrations were 39 296 pg/ml (range, 15 565-65 194 pg/ml) in patients and 9008 pg/ml (range, 2622-20 880 pg/ml) in controls (P = 0.005).
###end p 43
###begin p 44
###xml 0 61 0 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Serum concentrations of TGF-&#946; in BDI patients and controls</bold>
###xml 165 167 159 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 40 48 <span type="species:ncbi:9606">patients</span>
###xml 106 114 <span type="species:ncbi:9606">patients</span>
Serum concentrations of TGF-beta in BDI patients and controls. TGF-beta concentrations were higher in BDI patients, who had a mean concentration of 39 296.36 pg/ml (P = 0.005 compared with controls).
###end p 44
###begin title 45
###xml 0 8 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGF-&#946;</italic>
###xml 10 15 7 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smad7</italic>
###xml 17 22 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col I</italic>
###xml 24 31 21 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col III</italic>
###xml 33 39 30 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col IV</italic>
###xml 45 51 42 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PAI-1 </italic>
TGF-beta, Smad7, Col I, Col III, Col IV, and PAI-1 gene expression
###end title 45
###begin p 46
###xml 120 125 117 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smad7</italic>
###xml 127 132 124 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col I</italic>
###xml 134 141 131 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col III</italic>
###xml 143 149 140 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col IV</italic>
###xml 155 161 152 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PAI-1 </italic>
###xml 290 292 284 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 309 311 303 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4A</xref>
###xml 409 411 403 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 428 430 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4B</xref>
###xml 232 240 <span type="species:ncbi:9606">patients</span>
###xml 374 382 <span type="species:ncbi:9606">patients</span>
To evaluate the differential gene expression, we quantified the level of TGF-beta mRNA expression and its target genes, Smad7, Col I, Col III, Col IV, and PAI-1 in both groups. The mean TGF-beta mRNA level was 11-fold higher in BDI patients (11.59 REU) than in the controls (liver donors) (P = 0.138) (Figure 4A). Smad7 mRNA expression showed a similar pattern: 6.69 REU in patients and 1.12 REU in controls (P = 0.005) (Figure 4B).
###end p 46
###begin p 47
###xml 0 61 0 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRNA expression of TGF-&#946; and gene targets by real-time PCR</bold>
###xml 171 179 <span type="species:ncbi:9606">patients</span>
mRNA expression of TGF-beta and gene targets by real-time PCR. TGF-beta (A), Smad7 (B), Col II (C), Col III, (D), Col IV (E), and PAI-1 (F) mRNA levels were higher in BDI patients than in controls, although the differences were significant only for Smad7, Col I, and PAI-1 expression.
###end p 47
###begin p 48
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4C</xref>
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4D</xref>
###xml 294 296 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4E</xref>
###xml 325 327 325 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4F</xref>
###xml 100 108 <span type="species:ncbi:9606">patients</span>
###xml 167 175 <span type="species:ncbi:9606">patients</span>
###xml 378 386 <span type="species:ncbi:9606">patients</span>
Collagen mRNA expression was higher in the BDI group. The mean level of Col I mRNA was 26.86 REU in patients and 1.35 REU in controls (P = 0.012) (Figure 4C). The BDI patients showed a homogeneous pattern of Col III, mRNA expression (mean 18.84 REU) (Figure 4D). Col IV (mean 11.77 REU; Figure 4E) and PAI-1 (mean 22.18 REU, P = 0.001; Figure 4F) were also overexpressed in BDI patients.
###end p 48
###begin p 49
###xml 15 16 15 16 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s</sub>
###xml 145 146 142 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 220 222 217 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IV</italic>
The Spearman (rs) correlation showed that the Smad7 mRNA level correlated positively with the level of TGF-beta, Col I, and Col III, mRNA (Table 3). As expected, the mRNA expression of all analyzed genes, except for Col IV, correlated significantly with the increase in serum TGF-beta concentration (data not shown), probably because of the direct influence of TGF-beta signaling on the expression of ECM proteins.
###end p 49
###begin p 50
Correlation of Smad7 mRNA expression with the expression of TGF-beta, Col I, Col III, Col IV, and PAI-1
###end p 50
###begin p 51
###xml 4 6 4 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
* = P < 0.05
###end p 51
###begin title 52
Discussion
###end title 52
###begin p 53
###xml 311 312 311 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 313 314 313 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
BDI causes biliary acid flow obstruction, increases bile deposition in hepatic tissue, and causes hepatocyte degeneration, cell death, and release of liver enzymes such as aminotransferases and AP. Additionally, inflammatory cells migrate to the injured tissue, which contributes to secondary biliary cirrhosis[7,8].
###end p 53
###begin p 54
###xml 87 89 84 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 90 92 87 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 234 236 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 237 239 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 482 484 473 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 485 487 476 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 286 294 <span type="species:ncbi:9606">patients</span>
###xml 460 463 <span type="species:ncbi:10116">rat</span>
TGF-beta is a pleiotropic molecule involved in ECM proteins expression in fibrogenesis[24,25]. There is some controversy about whether the serum TGF-beta concentration can be correlated with hepatic injury in different liver diseases[26,27]. Despite this controversy, we found that BDI patients have increased serum concentrations of this protein, perhaps reflecting the overexpression of this cytokine in the liver. mRNA TGF-beta expression also increases in rat liver cholestasis[20,28].
###end p 54
###begin p 55
###xml 13 15 13 15 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 35 41 35 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smad7 </italic>
###xml 403 409 400 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smad7 </italic>
###xml 506 514 <span type="species:ncbi:9606">patients</span>
Dooley et al[20] demonstrated that Smad7 (overexpressed through an adenovirus containing Smad7 cDNA) inhibits TGF-beta signal transduction and influences the extent of fibrosis when used as preventive therapy in a bile duct ligation (BDL) model of fibrosis. These results suggest that Smad7 is a potential therapeutic tool for liver fibrosis and cirrhosis. The aim of our study was to determine whether Smad7 expression correlates with the gene expression of TGF-beta, Col I, Col III, Col IV, and PAI-1 in patients with liver fibrosis caused by BDI.
###end p 55
###begin p 56
###xml 14 16 14 16 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 408 410 408 410 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4 </sub>
###xml 474 480 <span type="species:ncbi:9606">humans</span>
Tahashi et al[16] showed that Smad7 protein has a critical role in acute and chronic liver injury and that the amount of this protein increases in acute and decreases in chronic liver injury, along with an associated decrease in collagen expression. Our results showing increased Smad7 mRNA expression along with the collagens I, III and IV seem to contradict those of Tahashi et al. However, they used a CCl4 model that produces damage similar to that caused by alcohol in humans and not a BDL model.
###end p 56
###begin p 57
###xml 14 23 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGF-&#946; </italic>
###xml 132 138 129 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smad7 </italic>
###xml 205 211 202 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smad7 </italic>
###xml 490 496 484 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smad7 </italic>
###xml 621 623 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 646 652 637 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smad7 </italic>
###xml 931 933 919 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 1057 1059 1045 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 1060 1062 1048 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 1152 1154 1140 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 1391 1393 1379 1381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 1394 1396 1382 1384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 65 73 <span type="species:ncbi:9606">patients</span>
###xml 162 170 <span type="species:ncbi:9606">patients</span>
###xml 398 406 <span type="species:ncbi:9606">patients</span>
###xml 730 733 <span type="species:ncbi:10116">rat</span>
We found that TGF-beta mRNA expression was 11-fold higher in BDI patients than in liver donors. This contrasts with a 6-fold higher Smad7 expression level in BDI patients. An increase in the expression of Smad7 must correlate with a reduction of the expression of fibrogenic molecules because of the direct negative feedback in TGF-beta signaling. Although we found higher Smad7 mRNA expression in patients, expression of the mRNA for collagens and PAI-1 also increased, demonstrating that Smad7 expression is not enough to inhibit TGF-beta signaling. These results are similar to those reported recently by Seyhan et al[29] who found continuous Smad7 augmentation along with liver fibrosis cholestasis induced in an experimental rat model was insufficient to blunt fibrogenesis. This result may reflect the observation that the transcriptional regulation of ECM proteins can be directed through another TGF-beta dependent pathway[30], such as connective tissue growth factor (CTGF), a growth factor that is recognized as a fibrogenic molecule in the liver[31,32]. Smad7 expression is regulated by two mechanisms: transcription and protein degradation[33]. The Smad7 transcriptional regulation is mediated by the Ski protein, which inhibits the Smad7 promoter, and the posttransductional regulation is mediated through the effects of Smurf and Jab1 proteins, which promote Smad7 degradation[34,35].
###end p 57
###begin p 58
###xml 386 388 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 292 300 <span type="species:ncbi:9606">patients</span>
###xml 532 540 <span type="species:ncbi:9606">patients</span>
We found a strong positive correlation of Smad7 mRNA expression with TGF-beta, Col I and Col III mRNA expression. The mRNA expression levels were 6.69, 11.59, 26.86, and 18.84 REU, respectively. We also observed a significant amount of fibrotic tissue deposition in the liver biopsies of BDI patients. In the literature, there is one report on increased Smad7 levels in tissue biopsies[36]. In this study, we were limited to analyzing only mRNA expression, and the expression of Smad7 and of ECM proteins need to be measured in BDI patients.
###end p 58
###begin p 59
###xml 194 200 <span type="species:ncbi:9606">humans</span>
We emphasize that most of the information about the fibrotic process and the molecules involved had been obtained from experimental models (animals and cell cultures). This is the first work in humans to focus on the mRNA expression of ECM proteins and their relationship to Smad7.
###end p 59
###begin p 60
###xml 64 72 <span type="species:ncbi:9606">patients</span>
###xml 340 348 <span type="species:ncbi:9606">patients</span>
The clinical parameters of biliary obstruction evaluated in the patients (AST, ALT, DB, and ALP concentrations) did not correlate with the gene expression levels, serum TGF-beta concentration, or fibrosis percentage. We found no correlation between the lesion type and fibrosis percentage. Type 3 lesion was the most frequent lesion in the patients (11 from 14), but this type was not related to the mRNA expression or liver fibrosis.
###end p 60
###begin p 61
###xml 196 198 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 199 201 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 252 260 <span type="species:ncbi:9606">patients</span>
Additionally, gene polymorphisms of TGF-beta (non coding -509 C/T and coding codon 10, codon 25, codon 263) have been associated with modified serum levels of this cytokine in different diseases [37-39]. We showed increased serum levels of TGF-beta in patients with BDI. In this study, we did not evaluate any of the TGF-beta polymorphisms. It will be important to plan further studies to determine if serum TGF-beta levels are more affected by the polymorphisms rather than the presence of bile duct injury.
###end p 61
###begin p 62
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 370 378 <span type="species:ncbi:9606">patients</span>
A recent report demonstrated the predominance of a single nucleotide polymorphism at codon 25 in cirrhotic, but not healthy subjects of Mexican origin[40]. It will also be interesting to determine if there exists a strong relationship between Smad7 and TGF-beta dependent genes such as collagens, PAI-1, TIMPs, and others that lead to extracellular matrix deposition in patients with different polymorphisms for TGF-beta.
###end p 62
###begin title 63
Conclusion
###end title 63
###begin p 64
###xml 187 193 184 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smad7 </italic>
###xml 238 257 235 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGF-&#946;, collagens</italic>
###xml 263 268 257 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PAI-1</italic>
###xml 124 132 <span type="species:ncbi:9606">patients</span>
###xml 339 347 <span type="species:ncbi:9606">patients</span>
We found augmented serum concentration of TGF-beta and an increase in the percentage of fibrotic tissue in the liver of BDI patients. Contrary to expected results, the 6-fold increase in Smad7 expression did not inhibit the expression of TGF-beta, collagens, and PAI-1. We also observed greater expression of Col I and Col III mRNA in BDI patients and significant correlations between their expression and TGF-beta concentration and Smad7 mRNA expression.
###end p 64
###begin title 65
Competing interests
###end title 65
###begin p 66
The authors declare that they have no competing interests.
###end p 66
###begin title 67
Authors' contributions
###end title 67
###begin p 68
###xml 331 339 <span type="species:ncbi:9606">patients</span>
MPAC performed the experimental work and data analysis, searched the scientific literature, and drafted and edited the manuscript. AMD participated in the design of the project and gave funding support. IYS and OPM participated in the collection of samples. JMHS, SHH, and RAM were responsible for obtaining clinical data from the patients. MVM contributed substantially to the writing of the manuscript, MFM and JSO contributed to the conceptualization of the study, and VDR conceived and designed the study. All authors read and approved the final manuscript.
###end p 68
###begin title 69
Pre-publication history
###end title 69
###begin p 70
The pre-publication history for this paper can be accessed here:
###end p 70
###begin p 71

###end p 71
###begin title 72
Acknowledgements
###end title 72
###begin p 73
This work was supported by CONACYT grant 33331-M to Vidal Delgado Rizo, PhD, and CONACYT grant 13801 to Alejandra Miranda Diaz, MD, PhD.
###end p 73
###begin p 74
We thank Jesse Haramati for the English translation.
###end p 74
###begin article-title 75
###xml 8 15 <span type="species:ncbi:9606">infants</span>
Mexican infants with extrahepatic biliary atresia display different fibrosis activity
###end article-title 75
###begin article-title 76
Surgical repair after bile duct and vascular injuries during laparoscopic cholecystectomy: when and how?
###end article-title 76
###begin article-title 77
Laparoscopic iatrogeny of the hepatic hilum as an indication for liver transplantation
###end article-title 77
###begin article-title 78
Right hepatic lobectomy for recurrent cholangitis after combined bile duct and right hepatic artery injury during laparoscopic cholecystectomy: a report of two cases
###end article-title 78
###begin article-title 79
Long-term results of surgical repair of bile duct injuries following laparoscopic cholecystectomy
###end article-title 79
###begin article-title 80
###xml 133 136 <span type="species:ncbi:10116">rat</span>
Treatment with anti-transforming growth factor beta antibodies influences an altered pattern of cytokines gene expression in injured rat liver
###end article-title 80
###begin article-title 81
TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway
###end article-title 81
###begin article-title 82
Interaction between GC box binding factors and Smad proteins modulates cell lineage-specific alpha 2(I) collagen gene transcription
###end article-title 82
###begin article-title 83
Transcriptional control by the TGF-beta/Smad signaling system
###end article-title 83
###begin article-title 84
Transforming growth factor beta 1 dependent regulation of Tenascin-C in radiation impaired wound healing
###end article-title 84
###begin article-title 85
Identification of novel TGF-beta/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach
###end article-title 85
###begin article-title 86
Smad-dependent and Smad-independent pathways in TGF-beta family signalling
###end article-title 86
###begin article-title 87
###xml 95 98 <span type="species:ncbi:10116">rat</span>
Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury
###end article-title 87
###begin article-title 88
Smad7 in TGF-beta-mediated negative regulation of gut inflammation
###end article-title 88
###begin article-title 89
###xml 92 96 <span type="species:ncbi:10090">mice</span>
Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice
###end article-title 89
###begin article-title 90
###xml 87 93 <span type="species:ncbi:10090">murine</span>
Sustained activation of fibroblast transforming growth factor-beta/Smad signaling in a murine model of scleroderma
###end article-title 90
###begin article-title 91
###xml 74 78 <span type="species:ncbi:10116">rats</span>
Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats
###end article-title 91
###begin article-title 92
Deficient Smad7 expression: a putative molecular defect in scleroderma
###end article-title 92
###begin article-title 93
Effects of Chinese traditional compound, JinSanE, on expression of TGF-beta1 and TGF-beta1 type II receptor mRNA, Smad3 and Smad7 on experimental hepatic fibrosis in vivo
###end article-title 93
###begin article-title 94
Iatrogenic injury to the bile duct: a working classification for radiologists
###end article-title 94
###begin article-title 95
Transforming growth factor beta signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts. TGFbeta signal transduction during transdifferentiation of hepatic stellate cells
###end article-title 95
###begin article-title 96
Liver fibrosis -- from bench to bedside
###end article-title 96
###begin article-title 97
###xml 107 115 <span type="species:ncbi:9606">children</span>
Serum concentration of transforming growth factor (TGF)-beta 1 does not predict advanced liver fibrosis in children with chronic hepatitis B
###end article-title 97
###begin article-title 98
###xml 149 157 <span type="species:ncbi:9606">patients</span>
Serum level of transforming growth factor-beta1 (TGF-beta1) and the expression of TGF-beta receptor type II in peripheral blood mononuclear cells in patients with autoimmune hepatitis
###end article-title 98
###begin article-title 99
###xml 41 45 <span type="species:ncbi:10116">rats</span>
Long-term treatment of bile duct-ligated rats with rapamycin (sirolimus) significantly attenuates liver fibrosis: analysis of the underlying mechanisms
###end article-title 99
###begin article-title 100
Liver fibrogenesis due to cholestasis is associated with increased Smad7 expression and Smad3 signaling
###end article-title 100
###begin article-title 101
Increased phosphorylation and activation of mitogen-activated protein kinase p38 in scleroderma fibroblasts
###end article-title 101
###begin article-title 102
###xml 98 101 <span type="species:ncbi:10116">rat</span>
Proliferating bile duct epithelial cells are a major source of connective tissue growth factor in rat biliary fibrosis
###end article-title 102
###begin article-title 103
###xml 0 3 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
HCV core protein promotes liver fibrogenesis via up-regulation of CTGF with TGF-beta1
###end article-title 103
###begin article-title 104
Fine tuning and cross-talking of TGF-beta signal by inhibitory Smads
###end article-title 104
###begin article-title 105
Jab1/CSN5, a component of the COP9 signalosome, regulates transforming growth factor beta signaling by binding to Smad7 and promoting its degradation
###end article-title 105
###begin article-title 106
Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation
###end article-title 106
###begin article-title 107
Role of transforming growth factor-beta signaling pathway in pathogenesis of benign biliary stricture
###end article-title 107
###begin article-title 108
Genetic control of the circulating concentration of transforming growth factor type beta1
###end article-title 108
###begin article-title 109
###xml 129 140 <span type="species:ncbi:11103">hepatitis C</span>
Transforming growth factor-beta1 gene polymorphisms are associated with progression of liver fibrosis in Caucasians with chronic hepatitis C infection
###end article-title 109
###begin article-title 110
Elevated serum level and gene polymorphisms of TGF-beta1 in gastric cancer
###end article-title 110
###begin article-title 111
###xml 58 66 <span type="species:ncbi:9606">patients</span>
Fibrogenic polymorphisms (TGF-beta, PAI-1, AT) in Mexican patients with established liver fibrosis. Potential correlation with pirfenidone treatment
###end article-title 111

